Raymond James analyst Michael Rose lowered the firm’s price target on Cullen/Frost to $150 from $165 and keeps an Outperform rating on the shares. Cullen/Frost’s Q4 results exceeded consensus expectations, with relatively solid results where greater than forecast NIM expansion more than offset a decline in average earning assets to fuel stronger than forecast net interest income, the analyst tells investors in a research note. The initial outlook for 2023 contemplates a higher noninterest expense outlook vs. our prior forecasts, the firm notes.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on CFR:
- Cullen/Frost CFO says current mean of 2023 consensus EPS estimates ‘reasonable’
- CULLEN/FROST REPORTS 4th QUARTER AND 2022 ANNUAL RESULTS
- Cullen/Frost reports Q4 EPS $2.91, consensus $2.75
- BofA upgrades Cullen/Frost to Buy, calls ‘best pure-play on Texas growth’
- Cullen/Frost upgraded to Buy from Neutral at BofA